What You Should Know:– Medidata announced that Allucent, a contract research organization (CRO) bringing innovation to biopharma companies, is expanding the global use of Medidata’s Clinical Cloud to advance its end-to-end clinical trial operations offering. – The agreement expands Allucent’s existing utilization of Medidata technologies. These include Rave EDC, eCOA, RTSM, and Rave Imaging, in support…
Continue Reading
The latest Digital Health news industry round-up includes an award of £1.4m for Mendelian to further develop its AI solutions, a pilot for a state-of-the-art prehabilitation programme at James Paget University Hospitals and the…
Continue Reading
What You Should Know:– Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue acquires Mountain View, CA-based Crosscope. Financial details of the acquisition were not…
Continue Reading
Susan Hill, VP & General Manager, Customer Engagement at IQVIAThe commercial life science industry continues to undergo a radical shift in the way it interacts with healthcare providers (HCPs) and consumers. In today’s complex,…
Continue Reading
The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies.
In the current digital environment, businesses are constantly bombarded with data. That data comes in all shapes…
Top News
Transcarent will acquire virtual primary care company 98point6’s care delivery division — which includes an AI-powered chatbot, physician group, and self-insured employer business — for $100 million.
Transcarent, which has relied on contracted clinicians,…
“If you can do it right, the hybrid model is one of the ways by which you can actually operationalize telehealth in a broader context,” said Sara Vaezy, chief strategy and digital officer for…
Continue Reading
Patients whose blood cancer advances after initial treatments have one last therapeutic option: the engineering of their immune cells into a living medicine. But cancer is crafty and it often finds a way to…
Continue Reading
Hybrid fertility and reproductive care company Kindbody scored a whopping $100 million from life sciences investment firm Perceptive Advisors, bringing its total raise to $290 million and its valuation to $1.8 billion. WHAT ITS FOR
Kindbody…
Life-sciences companies faced fewer class-action securities lawsuits last year, continuing a trend of declining litigation over the last few years, according to a report published in February by the law firm Dechert LLP.Investors filed…
Continue Reading
